Familial risk of cancer: Data for clinical counseling and cancer genetics

被引:78
作者
Hemminki, K
Li, XJ
Czene, K
机构
[1] German Canc Res Ctr, DKFZ, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Novum, Dept Biosci, Huddinge, Sweden
关键词
familial cancers; heritable cancer; clinical counseling; familial risk;
D O I
10.1002/ijc.11478
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. Medically verified data on familial risks have not been available for all types of cancer. The nationwide Swedish Family-Cancer Database includes all Swedes born in 1932 and later (0-to 68-year-old offspring) with their parents, totaling over 10.2 million individuals. Cancer cases were retrieved from the Swedish Cancer Registry up to year 2000. Standardized incidence ratios (SIR) and 95% confidence limits (Cl) were calculated for age-specific familial risk in offspring by an exact proband status. The familial risks for offspring cancer were increased at 24/25 sites from concordant cancer in only the parent, at 20/21 sites from a sibling proband and at 12/12 sites from a parent and sibling proband. The highest SIRs by parent were for Hodgkin's disease (4.88) and testicular (4.26), non-medullary thyroid (3.26), ovarian (3.15) and esophageal (3.14) cancer and for multiple myeloma (3.33). When a sibling was affected, even prostate, renal, squamous cell skin, endocrine, gastric and lung cancer and leukemia showed SIRs in excess of 3.00. The highest cumulative risks were found for familial breast (5.5%) and prostate (4.2%) cancers. We identified reliable familial risks for 24 common neoplasms, most of which lack guidelines for clinical counseling or action level. If, for example, a familial SIR of 2.2 would be use as an action level, counseling would be needed for most cancers at some diagnostic age groups. The present data provide the basis for clinical counseling. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 66 条
[1]   Accuracy of case-reported family history of melanoma in Queensland, Australia [J].
Aitken, JF ;
Youl, P ;
Green, A ;
MacLennan, R ;
Martin, NG .
MELANOMA RESEARCH, 1996, 6 (04) :313-317
[2]  
Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894
[3]   Genetic and environmental influences in the development of multiple primary melanoma [J].
Burden, AD ;
Newell, J ;
Andrew, N ;
Kavanagh, G ;
Connor, JM ;
MacKie, RM .
ARCHIVES OF DERMATOLOGY, 1999, 135 (03) :261-265
[4]   Genomic medicine: Genetic testing [J].
Burke, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (23) :1867-1875
[5]  
Carstensen B, 1996, INT J CANCER, V68, P428
[6]  
*CTR EP, 2000, CANC INC SWED 1998
[7]   Kidney cancer in the Swedish family cancer database: Familial risks and second primary malignancics [J].
Czene, KA ;
Hemminki, K .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1806-1813
[8]   New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections [J].
Doeberitz, MV .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (17) :2229-2242
[9]   Familial testicular cancer and second primary cancers in testicular cancer patients by histological type [J].
Dong, C ;
Lönnstedt, I ;
Hemminki, K .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (15) :1878-1885
[10]  
Dong CH, 2001, INT J CANCER, V92, P144